Eterna Therapeutics Inc. (ERNA)
NASDAQ · Healthcare
Eterna Therapeutics Inc. Long Term Debt 2010–2024
Eterna Therapeutics Inc. annual long term debt history from 2013 to 2020. Long term debt refers to financial obligations that are due more than one year in the future.
- Eterna Therapeutics Inc. long term debt as of December 31, 2020: 532,000, a 85.81% decrease year-over-year.
- Eterna Therapeutics Inc. long term debt for 2020 were 532,000, a 85.81% decrease from 2018.
- Eterna Therapeutics Inc. long term debt for 2018 were 3.8M, a 26.80% decrease from 2017.
- Eterna Therapeutics Inc. long term debt for 2017 were 5.1M, a 36.84% decrease from 2016.
- Eterna Therapeutics Inc. long term debt for 2016 were 8.1M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Eterna Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2020 | $1 |
| 2018 | $4 |
| 2017 | $5 |
| 2016 | $8 |
| 2015 | $7 |
| 2014 | $5 |
| 2013 | $2 |
Eterna Therapeutics Inc. Long Term Debt — FAQ
Eterna Therapeutics Inc. (ERNA) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ERNA's long term debt history?
The chart and table above show Eterna Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.